Combination Trans Arterial Chemoembolization (TACE) Plus Sorafenib for the Management of Unresectable Hepatocellular Carcinoma: A Systematic Review of the Literature

被引：0
|
作者：
O. Abdel-Rahman
Z. A. Elsayed
机构：
[1] Ain Shams University,Clinical Oncology Department, Faculty of Medicine
来源：
Digestive Diseases and Sciences | 2013年 / 58卷
关键词：
Hepatocellular carcinoma; TACE; Sorafenib; Combined treatment;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3389 / 3396
页数：7
相关论文
共 50 条
  • [1] Combination Trans Arterial Chemoembolization (TACE) Plus Sorafenib for the Management of Unresectable Hepatocellular Carcinoma: A Systematic Review of the Literature
    Abdel-Rahman, O.
    Elsayed, Z. A.
    DIGESTIVE DISEASES AND SCIENCES, 2013, 58 (12) : 3389 - 3396
  • [2] Efficacy of transcatheter arterial chemoembolization (TACE) in combination with sorafenib for the treatment of unresectable hepatocellular carcinoma in Chinese patients
    Qu, Xudong
    Wang, Jianhua
    Yan, Zhiping
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [3] Transarterial chemoembolization plus sorafenib for the management of unresectable hepatocellular carcinoma: a systematic review and meta-analysis
    Li, Lin
    Zhao, Wenzhuo
    Wang, Mengmeng
    Hu, Jie
    Wang, Enxin
    Zhao, Yan
    Liu, Lei
    BMC GASTROENTEROLOGY, 2018, 18
  • [4] Transarterial chemoembolization plus sorafenib for the management of unresectable hepatocellular carcinoma: a systematic review and meta-analysis
    Lin Li
    Wenzhuo Zhao
    Mengmeng Wang
    Jie Hu
    Enxin Wang
    Yan Zhao
    Lei Liu
    BMC Gastroenterology, 18
  • [5] Safety of transarterial chemoembolization plus sorafenib combination treatment in unresectable hepatocellular carcinoma
    Sinakos, Emmanouil
    Dedes, Ioannis
    Papalavrentios, Lavrentis
    Drevelegas, Antonios
    Akriviadis, Evangelos
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2010, 45 (04) : 511 - 512
  • [6] Combination of donafenib and anti-PD-1 antibody plus trans-arterial chemoembolization (TACE) in unresectable hepatocellular carcinoma (uHCC).
    Gu, Shanzhi
    Tan, Yulin
    Zhou, Huan
    Hu, Hongtao
    Zheng, Tongsen
    Zheng, Zhendong
    Zhu, Xu
    Yuan, Mu
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E16197 - E16197
  • [7] Sorafenib plus transarterial chemoembolization for unresectable hepatocellular carcinoma
    Tsilimigras, Diamantis I.
    Pawlik, Timothy M.
    ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (23)
  • [8] Evaluation of transcatheter arterial chemoembolization (TACE) plus sorafenib in Chinese patients with unresectable hepatocellular carcinoma: A subgroup analysis of START trial.
    Han, Guohong
    Yang, Jijin
    Shao, Guoliang
    Teng, Gaojun
    Wang, Maoqiang
    Yang, Jianyong
    Liu, Zhaoyu
    Feng, Gansheng
    Yang, Renjie
    Lu, Ligong
    Chao, Yee
    Wang, Jianhua
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [9] Efficacy and adverse events of transcatheter arterial chemoembolization in combination with sorafenib in the treatment of unresectable hepatocellular carcinoma
    Yao, Xuesong
    Yan, Dong
    Liu, Dezhong
    Zeng, Huiying
    Li, Huai
    MOLECULAR AND CLINICAL ONCOLOGY, 2015, 3 (04) : 929 - 935
  • [10] Trans-arterial chemoembolization (tace) in patients with hepatocellular carcinoma
    Menon, Sreekanth
    Ramachandran, T. M.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 : 724 - 724
12345